Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain

Background: Amplification of the MYCN oncogene is the most unfavorable genetic factor in neuroblastoma patients. However, knowledge about the clinical impact of low-level multiplication of MYCN is still insufficient. Therefore, we aimed to investigate the disease course in patients with different co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Autores principales: Szewczyk, Katarzyna, Wieczorek, Aleksandra, Młynarski, Wojciech, Janczar, Szymon, Woszczyk, Mariola, Gamrot, Zuzanna, Chaber, Radosław, Wysocki, Mariusz, Pogorzała, Monika, Bik-Multanowski, Mirosław, Balwierz, Walentyna
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6794702/
https://ncbi.nlm.nih.gov/pubmed/31649880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01018
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares